Neurogene (NGNE) Amortization of Deferred Charges (2019 - 2020)

Neurogene (NGNE) has 5 years of Amortization of Deferred Charges data on file, last reported at $304000.0 in Q3 2023.

• Quarterly Amortization of Deferred Charges rose 13.86% year-over-year to $304000.0 in Q3 2023, while the trailing twelve-month figure through Sep 2023 was $1.2 million (up 13.96% YoY) and the FY2022 annual result came in at $1.1 million, up 8.24% from the prior year.
• Amortization of Deferred Charges rose to $304000.0 in Q3 2023, from $294000.0 in the prior quarter.
• In the past five years, Amortization of Deferred Charges ranged from a high of $1.0 million in Q3 2020 to a low of $3000.0 in Q2 2020.
• A 4-year average of $312600.0 and a median of $265000.0 in 2021 frame the typical range for Amortization of Deferred Charges.
• The widest YoY moves for Amortization of Deferred Charges: up 7533.33% in 2021, down 76.4% in 2021.
• Tracing NGNE's Amortization of Deferred Charges over 4 years: stood at $252000.0 in 2020, then dropped by 4.37% to $241000.0 in 2021, then advanced by 14.11% to $275000.0 in 2022, then grew by 10.55% to $304000.0 in 2023.
• The last three Amortization of Deferred Charges figures came in at $304000.0 (Q3 2023), $294000.0 (Q2 2023), and $286000.0 (Q1 2023), per Business Quant data.